The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
The role of cytokines in hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is a frequent malignancy worldwide with a high rate of metastasis. The hepatitis B and C viruses are considered major etiological factors associated with the development of HCC, particularly as a result of their induction of chronic inflammation. There is increasing evidence that the inflammatory process is inherently associated with many different cancer types, including HCC. Specifically, this review aims to cover evidence for the potential roles of cytokines, an important component of the immune system, in promoting HCC carcinogenesis and progression. A global summary of cytokine levels, functions, polymorphisms, and therapies with regard to HCC is presented. In particular, the role of proinflammatory Th1 and anti-inflammatory Th2 cytokine imbalances in the microenvironment of HCC patients with metastasis and the possible clinical significance of these findings are addressed. Overall, multiple studies, spanning many decades, have begun to elucidate the important role of cytokines in HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“mune cells, such as T lymphocytes, by producing a variety of cytokines and chemokines [173].”
BackgroundTumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Schaff, Z., & Csmos, G. (1994) · Cited by 1,868
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · cited 2×
“Another consequence of chronic inflammatory responses initiated by viral infection is the release of free radicals, such as reactive oxygen species and NO reactive species [13].”
BackgroundEstimates of the worldwide mortality from 25 cancers in 1990
Pisani, P., Parkin, D. M., Bray, F., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<18::aid-ijc5>3.0.co;2-m · Cited by 1,549
Seeger, C., & Mason, W. S. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.1.51-68.2000 · Cited by 1,451
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Martell, M., Esteban, J. I., Quer, J., Genescà, J., Weiner, A., Esteban, R., Guardia, J., & Gómez, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3225-3229.1992 · Cited by 930
The −308 tumor necrosis factor-α promoter polymorphism effects transcription
Kroeger, K. M., Carville, K. S., & Abraham, L. J. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00052-7 · Cited by 864
Pisani, P., Parkin, D. M., Bray, F., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991210)83:6<870::aid-ijc35>3.0.co;2-9 · Cited by 860
Budhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L.-X., Tang, Z.-Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.016 · Cited by 846
Self-citationTiollais, P., & Buendia, M.-A. (1991) · Scientific American · doi:10.1038/scientificamerican0491-116 · Cited by 830
Inflammatory Exposure and Historical Changes in Human Life-Spans
Finch, C. E., & Crimmins, E. M. (2004) · Science · doi:10.1126/science.1092556 · Cited by 754
Coca, S., Perez-Piqueras, J., Martinez, D., Colmenarejo, A., Saez, M. A., Vallejo, C., Martos, J. A., & Moreno, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2320::aid-cncr5>3.0.co;2-p · Cited by 716
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 715
Radaeva, S., Sun, R., Pan, H.-N., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 597
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells
Sloan-Lancaster, J., Evavold, B. D., & Allen, P. M. (1993) · Nature · doi:10.1038/363156a0 · Cited by 587
Separation of IL-4 Production from Th Cell Proliferation by an Altered T Cell Receptor Ligand
Evavold, B. D., & Allen, P. M. (1991) · Science · doi:10.1126/science.1833816 · Cited by 549
Donato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., Carli, M. D., Fiaccadori, F., & Ferrari, C. (1994) · Nature · doi:10.1038/369407a0 · Cited by 540
Leek, R. D., Landers, R. J., Harris, A. L., & Lewis, C. E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690158 · Cited by 451
Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.
Ando, K., Moriyama, T., Guidotti, L. G., Wirth, S., Schreiber, R. D., Schlicht, H. J., Huang, S. N., & Chisari, F. V. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1541 · Cited by 449
Targeting cyclooxygenase-2 in human neoplasia
Dannenberg, A. J., & Subbaramaiah, K. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00310-6 · Cited by 446
Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
Simonetti, R. G., Liberati, A., Angiolini, C., & Pagliaro, L. (1997) · Annals of Oncology · doi:10.1023/a:1008285123736 · Cited by 380
Hepatocellular Carcinoma-Cause, Treatment and Metastasis
Tang, Z.-Y. (2001) · World Journal of Gastroenterology · doi:10.3748/wjg.v7.i4.445 · Cited by 375
Immune Pathogenesis of Hepatocellular Carcinoma
Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P., & Chisari, F. V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.341 · Cited by 373
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
Butel, J. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.405 · Cited by 371
Nitric oxide-induced cellular stress and p53 activation in chronic inflammation
Hofseth, L. J., Saito, S., Hussain, S. P., Espey, M. G., Miranda, K. M., Araki, Y., Jhappan, C., Higashimoto, Y., He, P., Linke, S. P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237083100 · Cited by 355
Growth and spread of hepatocellular carcinoma: A review of 240 consecutive autopsy cases
Yuki, K., Hirohashi, S., Sakamoto, M., Kanai, T., & Shimosato, Y. (1990) · Cancer · doi:10.1002/1097-0142(19901115)66:10<2174::aid-cncr2820661022>3.0.co;2-a · Cited by 327
Hagen, T. M., Huang, S., Curnutte, J., Fowler, P., Martinez, V, Wehr, C. M., Ames, B. N., & Chisari, F. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12808 · Cited by 311
Temporal and spatial control of nucleophosmin by the Ran–Crm1 complex in centrosome duplication
Wang, W., Budhu, A., Forgues, M., & Wang, X. W. (2005) · Nature Cell Biology · doi:10.1038/ncb1282 · Cited by 296
Self-citationDi Bisceglie, A. M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07361-3 · Cited by 288
Bréchot, C., Gozuacik, D., Murakami, Y., & Paterlini-Bréchot, P. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0321 · Cited by 276
Tumor vascularity and tryptase‐positive mast cells correlate with a poor prognosis in melanoma
Ribatti, D., Ennas, M. G., Vacca, A., Ferreli, F., Nico, B., Orru, S., & Sirigu, P. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01152.x · Cited by 262
Large, M. K., Kittlesen, D. J., & Hahn, Y. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.931 · Cited by 260
Hussain, S. P., Raja, K., Amstad, P. A., Sawyer, M., Trudel, L. J., Wogan, G. N., Hofseth, L. J., Shields, P. G., Billiar, T. R., Trautwein, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220416097 · Cited by 248
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K.-I., Sata, M., Kohara, M., & Yoshimura, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012127 · Cited by 236
Kakimi, K., Lane, T. E., Wieland, S., Asensio, V. C., Campbell, I. L., Chisari, F. V., & Guidotti, L. G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1755 · Cited by 234
Donato, F., Tagger, A., Chiesa, R., Ribero, M. L., Tomasoni, V, Fasola, M., Gelatti, U., Portera, G., Boffetta, P., & Nardi, G. (1997) · Hepatology · doi:10.1002/hep.510260308 · Cited by 234
Bertoletti, A., Costanzo, A., Chisari, F. V., Levrero, M., Artini, M., Sette, A., Penna, A., Giuberti, T., Fiaccadori, F., & Ferrari, C. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.933 · Cited by 226
Cytokine gene polymorphisms in patients infected with hepatitis B virus
Ben-Ari, Z. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05847-1 · Cited by 222
Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.
Toyonaga, T., Hino, O., Sugai, S., Wakasugi, S., Abe, K., Shichiri, M., & Yamamura, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.614 · Cited by 214
Hepatitis B and C Viruses and Their Interaction in the Origin of Hepatocellular Carcinoma
Kaklamani, E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460150078027 · Cited by 201
Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma
Imada, A., Shijubo, N., Kojima, H., & Abe, S. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.01517.x · Cited by 195
Anzola, M. (2004) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2004.00521.x · Cited by 191
McGuinness, P. H., Painter, D., Davies, S., & McCaughan, G. W. (2000) · Gut · doi:10.1136/gut.46.2.260 · Cited by 181
Beckebaum, S., Zhang, X., Chen, X., Yu, Z., Frilling, A., Dworacki, G., Grosse-Wilde, H., Broelsch, C. E., Gerken, G., & Cicinnati, V. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0872 · Cited by 181
Deficiencies of GM-CSF and Interferon γ Link Inflammation and Cancer
Enzler, T., Gillessen, S., Manis, J. P., Ferguson, D., Fleming, J., Alt, F. W., Mihm, M., & Dranoff, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021258 · Cited by 179
Effect of Immune Globulin on the Prevention of Experimental Hepatitis C Virus Infection
Krawczynski, K., Alter, M. J., Tankersley, D. L., Beach, M., Robertson, B. H., Lambert, S., Kuo, G., Spelbring, J. E., Meeks, E., Sinha, S., et al. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.4.822 · Cited by 178
KAKUMU, S., OKUMURA, A., ISHIKAWA, T., YANO, M., ENOMOTO, A., NISHIMURA, H., YOSHIOKA, K., & YOSHIKAI, Y. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1997.4861382.x · Cited by 174
Ohno, S., Inagawa, H., Dhar, D. K., Fujii, T., Ueda, S., Tachibana, M., Suzuki, N., Inoue, M., Soma, G., & Nagasue, N. (2003) · PubMed · Cited by 171
Wang, Y., Kato, N., Hoshida, Y., Yoshida, H., Taniguchi, H., Goto, T., Moriyama, M., Otsuka, M., Shiina, S., Shiratori, Y., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50017 · Cited by 169
Mechanisms of Disease: inflammatory mediators and cancer prevention
Mann, J. R., Backlund, M. G., & DuBois, R. N. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0140 · Cited by 167
You, L.-R., Chen, C.-M., & Lee, Y.-H. W. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1672-1681.1999 · Cited by 160
Migita, K., Miyazoe, S., Maeda, Y., Daikoku, M., Abiru, S., Ueki, T., Yano, K., Nagaoka, S., Matsumoto, T., Nakao, K., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.026 · Cited by 154
Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma
Shin, H. D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg104 · Cited by 153
de Lalla, C., Galli, G., Aldrighetti, L. A., Romeo, R., Mariani, M., Monno, A., Nuti, S., Colombo, M., Callea, F., Porcelli, S. A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1417 · Cited by 153
Characteristics of hepatocellular carcinoma in Italy
Stroffolini, T., Andreoné, P., Andriulli, A., Ascione, A., Craxì, A., Chiaramonte, M., Galante, D., Manghisi, O. G., Mazzanti, R., Medaglia, C., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80122-0 · Cited by 153
Management of hepatocellular carcinoma.
Nakakura, E. K., & Choti, M. A. (2000) · PubMed · Cited by 150
Chau, G., Wu, C.-W., Lui, W., Chang, T.-J., Kao, H.-L., Wu, L., King, K., Loong, C., Hsia, C.-Y., & Chi, C. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00015 · Cited by 149
Forgues, M., Difilippantonio, M. J., Linke, S. P., Ried, T., Nagashima, K., Feden, J. P., Valerie, K. C., Fukasawa, K., & Wang, X. W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5282-5292.2003 · Cited by 145
Self-citationEffect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study
Jf, T., Jeng, J., Ho, M., Chang, W., Hsieh, M., Lin, Z., & Tsai, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.493 · Cited by 144
Tanaka, S., & Wands, J. R. (1996) · PubMed · Cited by 122
Role of NF-κB and Myc Proteins in Apoptosis Induced by Hepatitis B Virus HBx Protein
Su, F., Theodosis, C. N., & Schneider, R. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.215-225.2001 · Cited by 118
Immunopathogenesis of hepatitis C virus infection
Chang, K. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00068-5 · Cited by 117
Intrahepatic T Cells in Hepatitis B
Rehermann, B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1263 · Cited by 107
Hepatitis B virus in hepatocarcinogenesis
Feitelson, M. A. (1999) · Journal of Cellular Physiology · Cited by 107
Hira, E., Ono, T., Dhar, D. K., El-Assal, O. N., Hishikawa, Y., Yamanoi, A., & Nagasue, N. (2004) · Cancer · doi:10.1002/cncr.20818 · Cited by 106
Effect of cytokine genotypes on the hepatitis B virus‐hepatocellular carcinoma association
Nieters, A., Yuan, J., Sun, C., Zhang, Z., Stoehlmacher, J., Govindarajan, S., & Yu, M. C. (2005) · Cancer · doi:10.1002/cncr.20842 · Cited by 103
Okumoto, K., Hattori, E., Tamura, K., Kiso, S., Watanabe, H., Saito, K., Saito, T., Togashi, H., & Kawata, S. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.00882.x · Cited by 93
Expression and function of interleukin-8 in human hepatocellular carcinoma
Akiba, J., Yano, H., Ogasawara, S., Higaki, K., & Kojiro, M. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.2.257 · Cited by 93
Ryschich, E., Lizdenis, P., Ittrich, C., Benner, A., Stahl, S. H., Hamann, A., Schmidt, J., Knolle, P. A., Arnold, B., Hämmerling, G. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1636 · Cited by 86
Tsutsumi, T., Suzuki, T., Moriya, K., Yotsuyanagi, H., Shintani, Y., Fujie, H., Matsuura, Y., Kimura, S., Koike, K., & Miyamura, T. (2002) · Virology · doi:10.1006/viro.2002.1702 · Cited by 85
Immunopathogenesis of hepatitis C virus infection
Freeman, A. J., Marinos, G., Ffrench, R. A., & Lloyd, A. R. (2001) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2001.01036.x · Cited by 85
The interplay between innate and adaptive immunity regulates cancer development
de Visser, K. E., & Coussens, L. M. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0702-5 · Cited by 83
Perlemuter, G., Lettéron, P., Carnot, F., Zavala, F., Pessayre, D., Nalpas, B., & Bréchot, C. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00414-8 · Cited by 81
Bui, L. A., Butterfield, L. H., Kim, J. Y., Ribas, A., Seu, P., Lau, R., Glaspy, J. A., McBride, W. H., & Economou, J. S. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.18-2173 · Cited by 78
Kim, Y. C., Song, K.-S., Yoon, G., Nam, M., & Ryu, W. (2001) · Oncogene · doi:10.1038/sj.onc.1203840 · Cited by 77
Song, L. H., Binh, V. Q., Duy, D. N., Kun, J. F. J., Bock, C. –., Kremsner, P. G., & Luty, A. J. F. (2003) · Journal of Clinical Virology · doi:10.1016/s1386-6532(02)00271-8 · Cited by 75
Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
Lee, Y. I., 박의순, Choi, I., Yoon, S. K., Park, Y. M., & Lee, Y. I. (1998) · PubMed · Cited by 74
Urashima, T., Saigo, K., Kobayashi, S. S., Imaseki, H., Matsubara, H., Koide, Y., Asano, T., Kondō, Y., Koike, K., & Isono, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80241-3 · Cited by 71
Lin, S., Shu, P., Chang, C., Ng, A., & Hu, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4708 · Cited by 71
Wang, Y., Kato, N., Hoshida, Y., Otsuka, M., Taniguchi, H., Moriyama, M., Shiina, S., Kawabe, T., Ito, Y. M., & Omata, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1187-3 · Cited by 68
Lee, C. H., Choi, Y. H., Yang, S.-H., Lee, C. W., Ha, S., & Sung, Y. C. (2001) · Virology · doi:10.1006/viro.2000.0694 · Cited by 67
Ho, S., Wang, Y., Chen, H.-L., Chen, C., Chang, C., Wang, P.-J., Chen, H. H. W., & Guo, H. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000036173.99930.75 · Cited by 65
Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma
Stroffolini, T., Chiaramonte, M., Tiribelli, C., Villa, E., Simonetti, R. G., Rapicetta, M., Stazi, M. A., Bertin, T., Crocè, L. S., Trande, P., et al. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80670-1 · Cited by 64
長尾, 美., Nakajima, Y., Kanehiro, H., Hisanaga, M., Aomatsu, Y., Ko, S., Tatekawa, Y., Ikeda, N., Kanokogi, H., Urizono, Y., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.16470 · Cited by 62
Association between interleukin 6 promoter variants and chronic hepatitis B progression
Park, B. L., Lee, H., Kim, Y. J., Kim, J. Y., Jung, J. H., Kim, L. H., & Shin, H. D. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.11 · Cited by 62
Suppression of hepatitis C virus replicon by TGF-β
Murata, T., Ohshima, T., Yamaji, M., Hosaka, M., Miyanari, Y., Hijikata, M., & Shimotohno, K. (2004) · Virology · doi:10.1016/j.virol.2004.10.036 · Cited by 61
Understanding the Mechanisms of Sustained Signaling and T Cell Activation
Lanzavecchia, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1717 · Cited by 61
Viral infections and chemical exposures as risk factors for hepatocellular carcinoma in Vietnam
Cordier, S., Thủy, L. T. B., Verger, P., Bard, D., Dai, L. C., Larouzé, B., Dazza, M., Quynh, H. T., & Abenhaim, L. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550205 · Cited by 59
Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma
Wang, Z., Qiu, S.-J., Ye, S.-L., et al. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700375 · Cited by 54
Akbar, S. M. F., Abe, M., Murakami, H., Tanimoto, K., Kumagi, T., Yamashita, Y., Michitaka, K., Horiike, N., & Onji, M. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00606-1 · Cited by 53
Yuen, M., Norris, S. A., Evans, L. W., Langley, P. G., & Hughes, R. D. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202753416939 · Cited by 52
Natural and iatrogenic variation in hepatitis B virus
Ngui, S. L., Hallet, R., & Teo, C. G. (1999) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(199907/09)9:3<183::aid-rmv248>3.0.co;2-p · Cited by 52
Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection
Niro, G. A., Fontana, R., Gioffreda, D., Valvano, M. R., Lacobellis, A., Facciorusso, D., & Andriulli, A. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01166.x · Cited by 51
Expression of hepatitis C virus non‐structural 5A protein in the liver of transgenic mice
Majumder, M., Steele, R., Ghosh, A. K., Zhou, X., Thornburg, L. P., RAY, R. K., Phillips, N. J., & Ray, R. B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01337-1 · Cited by 51
Anti-inflammatory and antiviral effects of Glossogyne tenuifolia
Wu, M., Weng, C., Ding, H., & Wu, P.-J. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.08.017 · Cited by 48
Dumortier, J., Schönig, K., Oberwinkler, H., Löw, R., Giese, T., Bujard, H., Schirmacher, P., & Protzer, U. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302449 · Cited by 46
Shimizu, Y., Iwatsukï, S., Herberman, R. B., & Whiteside, T. L. (1991) · Cancer Immunology Immunotherapy · doi:10.1007/bf01789045 · Cited by 42
Wagner, K., Peters, M., Scholz, A., Benckert, C., Sanchez‐Ruderisch, H., Wiedenmann, B., & Rosewicz, S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.011 · Cited by 42
Margalit, M., Shibolet, O., Klein, A., Elinav, E., Alper, R., Thalenfeld, B. E., Engelhardt, D., Rabbani, E., & Ilan, Y. (2005) · International Journal of Cancer · doi:10.1002/ijc.20889 · Cited by 41
Tsai, J., Jeng, J., Ho, M., Chang, W., Lin, Z., & Tsai, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560502 · Cited by 41
Expression of interleukin-18, interferon-γ and interleukin-10 in hepatocellular carcinoma
Chia, C. S., Ban, K., Ithnin, H., Singh, H., Krishnan, R., Mokhtar, S., Malihan, N., & Seow, H. F. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00176-1 · Cited by 40
Bortolami, M., Venturi, C., Giacomelli, L., Scalerta, R., Bacchetti, S., Marino, F., Floreani, A., Lise, M., Naccarato, R., & Farinati, F. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80073-1 · Cited by 40
Sun, C., Farzadegan, H., You, S., Lu, S., Wu, M. H., Wolfe, L., Hardy, W., Huang, G., Yang, P., Lee, H., et al. (1996) · PubMed · Cited by 35
Interleukin‐6 inhibits cell proliferation in a rat model of hepatocellular carcinoma
Moran, D. M., Mayes, N., Koniaris, L. G., Cahill, P. A., & McKillop, I. H. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01083.x · Cited by 32
Effect of Hepatitis C Virus Core Protein on the Molecular Profiling of Human B Lymphocytes
Wu, C.-G., Budhu, A., Chen, S., Zhou, X., Popescu, N. C., Valerie, K. C., & Wang, X. W. (2006) · Molecular Medicine · doi:10.2119/2006-00020.wu · Cited by 32
Self-citationOhno, H., Kaneko, S., Lin, Y., Kobayashi, K., & Murakami, S. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199905)58:1<11::aid-jmv2>3.0.co;2-h · Cited by 30
Andrews, K. J., Ribas, A., Butterfield, L. H., Vollmer, C. M., Eilber, F. C., Dissette, V. B., Nelson, S. D., Shintaku, P. I., Mekhoubad, S., Nakayama, T., et al. (2000) · PubMed · Cited by 28
Chan-Fook, C., Jiang, W.-R., Clarke, B. E., Zitzmann, N., Maidens, C. M., McKeating, J. A., & Jones, I. M. (2000) · Virology · doi:10.1006/viro.2000.0407 · Cited by 28
Sundström, S., Ota, S., Dimberg, L. Y., Masucci, M. G., & Bergqvist, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2230-2239.2005 · Cited by 28
Tangkijvanich, P., Vimolket, T., Theamboonlers, A., Kullavanijaya, P., Suwangool, P., & Poovorawan, Y. (2000) · PubMed · Cited by 26
Yamaji, K., Nabeshima, S., Murata, M., Chong, Y., Furusyo, N., Ikematsu, H., & Hayashi, J. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0005-x · Cited by 26
Peng, B. G., Liu, S. Q., Kuang, M., He, Q., Totsuka, S., Huang, L., Huang, J.-F., Lu, M., Liang, L., Leong, K. W., et al. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01265.x · Cited by 24
Péron, J., Couderc, B. C., Rochaix, P., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2003.03295.x · Cited by 22
Szabó, G., Catalano, D., Bellerose, G., & Mandrekar, P. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200108000-00015 · Cited by 22
Legrand, A., Vadrot, N., Lardeux, B. R., Bringuier, A. F., Guillot, R., & Feldmann, G. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.00899.x · Cited by 19
Romieu, R. (1997) · International Immunology · doi:10.1093/intimm/9.10.1405 · Cited by 17
Kanaoka, Y., Yagi, T., Sadamori, H., Matsukawa, H., Matsuda, H., Inagaki, M., Ishikawa, T., Saito, S., Iwagaki, H., & Tanaka, N. (2002) · Journal of International Medical Research · doi:10.1177/147323000203000505 · Cited by 10
Ishikawa, M., Miyauchi, T., Yagi, K., et al. (1999) · World Journal of Surgery · doi:10.1007/s002689900568 · Cited by 7
Cited by
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Hernandez–Gea, V., Toffanin, S., Friedman, S. L., & Llovet, J. M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.002 · Cited by 722
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
Tang, A., Hallouch, O., Chernyak, V., Kamaya, A., & Sirlin, C. B. (2018) · Abdominal Radiology · doi:10.1007/s00261-017-1209-1 · Cited by 480
Capece, D., Fischietti, M., Verzella, D., Gaggiano, A., Cicciarelli, G., Tessitore, A., Zazzeroni, F., & Alesse, E. (2013) · BioMed Research International · doi:10.1155/2013/187204 · Cited by 408
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
Haybaeck, J., Zeller, N., Wolf, M. J., Weber, A., Wagner, U., Kurrer, M. O., Bremer, J., Iezzi, G., Graf, R., Clavien, P.-A., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.021 · Cited by 383
Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Yang, J. D., Kim, W. R., Coelho, R., Mettler, T. A., Benson, J. T., Sanderson, S. O., Therneau, T. M., Kim, B., & Roberts, L. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.08.019 · Cited by 266
Metadata
- Authors
- Budhu, A., & Wang, X. W.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-08-31
- Volume
- 80
- Issue
- 6
- Pages
- 1197-1213
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2165638318
- Cited by
- 319
- References
- 127
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.